One of the part of this testing utilizes written and verbal screening tests to diagnose people with very early Alzheimer’s symptoms, Mild Cognitive Impairment (MCI) or Mild Neurocognitive Disorder (MNCD). These occur as people progress from normal aging to early Alzheimer’s. These new ‘biomarker’ tests will be most helpful for identifying likely early cases and for helping to develop preventive strategies and treatments.
Another part of this testing looks at Brain Neurotransmitters that are involved in mood (i.e. Depression, Anxiety, etc) and memory. These urine analytes include:
Vanilmandelic Acid |
Homovanillic Acid |
5-OH-Indoleacetic Acid |
3-Methyl-4-OH-phenylglycol |
Kynurenic Acid |
Quinolinic Acid |
Kynurenic/Quinolinic Ratio |
|